UNSPSC 51351624: Estradiol hemihydrate

This classification denotes a therapeutic estradiol, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CXY7B3Q98Z. European Medicines Agency schedules Estradiol hemihydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11941MIG. Estradiol hemihydrate generally arises in the molecular formula 2C18H24O2.H2O. The term 'estradiol hemihydrate' is a European Pharmacopoeia designation. Most nations, for tariff and trade purposes, schedule estradiol hemihydrate under HS 29372300.

As of Q4 2014, ESTRADIOL HEMIHYDRATE remains US FDA's Preferred Term for this commodity. Estradiol hemihydrate bears US NLM identifiers UMLS ID C1320235 and NCI Concept Code C47992. SMILES: C[C@]12CC[C@@H]3C4CCC(CC4CC[C@H]3[C@@H]1CC[C@@H]2O)O.C[C@]12CC[C@@H]3C4CCC(CC4CC[C@H]3[C@@H]1CC[C@@H]2O)O.O.

UNSPSC 51351624 Estradiol hemihydrate is a Commodity code covering the procurement of this specific pharmaceutical active ingredient by state and local health systems, correctional facilities, and public health agencies. Estradiol hemihydrate is a form of estrogen used in hormone replacement therapy and certain cancer treatments, procured as a raw pharmaceutical material or finished formulation by public healthcare providers managing inpatient and outpatient medication inventories. State and local buyers under this code typically include state departments of corrections, state Medicaid programs, county health departments, municipal hospitals, and independent school districts with on-site medical clinics; repeat purchasing patterns cluster around institutions with ongoing endocrinology, oncology, or women's health services. The source contains no recent state and local contract opportunities tagged to this code, indicating either minimal recent solicitation activity or infrequent use of this specific commodity classification in publicly posted procurement records.

When state and local governments do source estradiol hemihydrate, procurement typically moves through cooperative purchasing agreements, standing orders with pharmaceutical wholesalers, or direct requisitions under state pharmaceutical contracts rather than through open-market competitive solicitations. The absence of posted opportunities under this Commodity code does not signal market inactivity — public health procurement in pharmaceuticals often consolidates through centralized state purchasing, group purchasing organizations, or pre-negotiated vendor relationships that are not individually advertised. Firms seeking to compete for estradiol hemihydrate supply should monitor state pharmaceutical contract awards, Medicaid managed-care RFPs naming pharmaceutical suppliers, and state correctional system supply agreements where this ingredient is most likely to appear.